Procter & Gamble Chief R&D Officer Receives Annual Equity Award Grant

Transaction Overview

On October 1, 2026, Victor Javier Aguilar Moses, Chief Research, Development & Innovation Officer of Procter & Gamble Co ($PG), was granted equity awards under The Procter & Gamble 2025 Stock and Incentive Compensation Plan:

1. Restricted Stock Units (RSUs): 5,732 shares of Common Stock awarded at $0 per share.
2. Stock Options: Right to buy 22,822 shares of Common Stock at an exercise price of $143.95 per share, vesting on October 1, 2029, and expiring on October 1, 2036.

Holdings After Transaction

• Direct Ownership: 55,243.0935 shares of Common Stock.
• Indirect Holdings:
  • 7,476.1294 shares held by Retirement Plan Trustee.
  • 428.6033 shares held by International Stock Ownership Plan (Mexico) Trustee.
• Derivative Holdings: 22,822 stock options.

Market & Governance Impact

This filing represents standard, scheduled annual equity incentive compensation for executive officers. As an acquisition via company grant rather than an open-market purchase, this transaction has Low trading significance.